Media coverage about Burcon NutraScience Corp (NASDAQ:BUR) (TSE:BU) has been trending positive this week, according to Alpha One Sentiment. Alpha One, a subsidiary of Accern, identifies negative and positive press coverage by analyzing more than twenty million blog and news sources in real time. Alpha One ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Burcon NutraScience Corp earned a news sentiment score of 0.44 on Alpha One’s scale. Alpha One also gave news stories about the biotechnology company an impact score of 0 out of 100, meaning that recent press coverage is extremely unlikely to have an impact on the company’s share price in the next several days.
Separately, ValuEngine upgraded Burcon NutraScience Corp from a “strong sell” rating to a “sell” rating in a research report on Wednesday, June 7th.
Shares of Burcon NutraScience Corp (BUR) opened at 1.09 on Friday. The firm’s market capitalization is $41.23 million. The stock has a 50 day moving average price of $1.13 and a 200 day moving average price of $1.60. Burcon NutraScience Corp has a 1-year low of $0.91 and a 1-year high of $2.86.
Burcon NutraScience Corp Company Profile
Burcon NutraScience Corp (Burcon) is a Canada-based company, which is engaged in development of functional and renewable plant proteins. The Company has developed a portfolio of composition, application and process patents originating from a core protein extraction and purification technology. The Company and its subsidiary have developed CLARISOY, a soy protein; and are developing Peazazz, a pea protein, and Puratein, Supertein and Nutratein, approximately three canola protein isolates.
Receive News & Ratings for Burcon NutraScience Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Burcon NutraScience Corp and related companies with MarketBeat.com's FREE daily email newsletter.